Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Stelara
Stelara
J&J's crown jewel Stelara faces another potential rival as biosim player Alvotech touts trial win
Fierce Pharma
Tue, 05/24/22 - 04:31 pm
Alvotech
Teva Pharmaceutical
JNJ
Stelara
AVT04
biosimilars
psoriasis
Could This Biosimilar Drug Candidate Create a Blockbuster for Amgen?
Motley Fool
Mon, 05/23/22 - 06:44 pm
Amgen
biosimilars
Stelara
JNJ
Janssen, Brickell and ViiV are Knocking on FDA's Door
BioSpace
Sat, 10/9/21 - 10:56 pm
FDA
Janssen
Stelara
juvenile psoriatic arthritis
Brickell Bio
sofpironium bromide gel
ViiV Healthcare
HIV
Triumeq
The top 15 blockbuster patent expirations coming this decade
Fierce Pharma
Mon, 07/12/21 - 11:08 am
patents
patent cliff
AbbVie
Humira
Merck
Keytruda
Bristol Myers Squibb
Revlimid
Pfizer
Eliquis
Regeneron
Eylea
JNJ
Stelara
Opdivo
GSK
Dolutegravir
Ibrance
Januvia
Eli Lilly
Trulicity
Novo Nordisk
Victoza
Amgen
Prolia
Xgeva
Novartis
Cosentyx
Takeda
Entyvio
J&J scraps late-stage study testing Stelara for lupus
Reuters
Sat, 06/27/20 - 11:40 pm
JNJ
Janssen
lupus
Stelara
clinical trials
Janssen trials ultrasound-guided approach to treating Crohn’s
Pharmaforum
Fri, 02/14/20 - 10:41 am
JNJ
Janssen
guided ultrasound
Stelara
Crohn's Disease
Janssen’s Stelara Wins FDA Approval for Ulcerative Colitis
BioSpace
Mon, 10/21/19 - 04:45 pm
JNJ
Janssen
Stelara
FDA
ulcerative colitis
UCB's bispecific beats J&J's Stelara in psoriasis phase 3
Fierce Biotech
Fri, 10/18/19 - 07:47 pm
UCB Pharma
bispecific antibodies
bimekizumab
JNJ
Stelara
psoriasis
Prescription drugs boost drives J&J forecasts higher, shares rise
Yahoo/Reuters
Tue, 10/15/19 - 09:52 am
JNJ
earnings
Stelara
Imbruvica
J&J gets Stelara okay in Europe for ulcerative colitis
Pharmaforum
Fri, 09/6/19 - 08:35 pm
JNJ
Stelara
Janssen
Europe
Most people pay less than $5 per month for the drug. But some pay $11,002
Stat
Wed, 04/17/19 - 09:45 am
JNJ
Janssen
Stelara
drug pricing
Stelara Shines in Three Year Crohn's Disease Study
CP Wire
Wed, 10/24/18 - 02:43 pm
Janssen
JNJ
Stelara
Crohn's Disease
clinical trials
Stelara Shines in Three Year Crohn's Disease Study
Wed, 10/24/18 - 10:05 am
Jannsen
JNJ
Stelara
Crohn's Disease
J&J's Stelara succeeds in chronic bowel disease study
Yahoo/Reuters
Tue, 10/9/18 - 11:21 am
JNJ
Stelara
ulcerative colitis
3 Drugs That Are Moving the Needle at Johnson & Johnson
Motley Fool
Thu, 04/19/18 - 09:17 am
JNJ
Darzalex
Zytiga
Stelara
earnings
Forget Remicade -- Here's How Johnson & Johnson Plans to Grow
Motley Fool
Wed, 03/14/18 - 11:34 am
JNJ
Stelara
Zytiga
Darzalex
oncology
immunology
Novartis goes 2-0 against J&J in psoriasis
Biopharma Dive
Wed, 01/17/18 - 11:36 am
Novartis
JNJ
psoriasis
Cosentyx
Stelara
J&J's Stelara shows promise against lupus in study
Yahoo/Reuters
Sun, 11/5/17 - 09:28 am
JNJ
Stelara
lupus
clinical trials
AbbVie boasts a PhIII sweep for top psoriasis contender risankizumab, but it has lots of competition
Endpoints
Thu, 10/26/17 - 09:28 am
AbbVie
psoriasis
risankizumab
Humira
Stelara
clinical trials
5 Key Drugs Critical to Johnson & Johnson's Future
Motley Fool
Sun, 10/22/17 - 09:50 am
JNJ
Stelara
Xarelto
Imbruvia
Zytiga
Darzalex
Pages
« first
‹ previous
1
2
3
4
5
next ›
last »